Highlights
NASDAQ: CATB       Catabasis Pharma
Last Price Today's Change   Day's Range   Trading Volume
7.00   0.00 (0.00%)  7.00 - 7.24  220,300

Overview

 
Avg Volume (4 weeks):121,138
4 Weeks Range:5.23 - 7.24
4 Weeks Price Volatility (%):
88.06%
52 Weeks Range:4.02 - 9.76
52 Weeks Price Volatility (%):
51.92%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Catabasis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of therapeutics based on its Safely Metabolized And Rationally Targeted, a linker drug discovery platform. The company's primary focus is on treatments for rare diseases. Its product pipeline includes CAT-1004, an oral small molecule for the treatment of duchenne muscular dystrophy, CAT-2054 for the treatment of hypercholesterolemia and CAT-4001 which is used for the treatment of rare neurodegenerative diseases, such as Friedreich's ataxia and amyotrophic lateral sclerosis. Geographically it operates thorough United States and derives revenue from sale of products.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers